Erratum to: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)

I-SPY2 Investigators

Research output: Contribution to journalComment/debate

Abstract

In the original version of the published article, Constantine Godellas was mistakenly omitted from the Author list and Author Contributions statement. Constantine Godellas has been added as the 29th Author, and is affiliated with Loyola University Medical Center, Maywood, IL, United States. The author contributions statement has been updated as follows: “Author Contributions Statement: Judy C. Boughey conducted the review of current protocols, led the effort to establish new I-SPY standards and was the principal author of the manuscript. Laura Esserman co-led the review and standardization processes. Michael D. Alvarado, Rachael B. Lancaster, Fraser Symmans, W, Rita Mukhtar, Jasmine Wong, Cheryl Ewing, David Potter, Todd Tuttle, Tina Hieken, Jodi Carter, James Jakub, Henry Kaplan, Claire Buchanan, Nora Jaskowiak, Husain Sattar, Jeffrey Mueller, Rita Nanda, Claudine Isaacs, Paula Pohlmann, Filipa Lynce, Eleni Tousimis, Jay Zeck, M. Catherine Lee, Julie Lang, Paulette Mhawech-Fauceglia, Roshni Rao, Bret Taback, Margaret Chen, Kevin Kalinsky, Hanina Hibshoosh, Brigid Killelea, Constantine Godellas, and Tara Sanft provided medical and scientific expertise/opinion towards the development of I-SPY standards. Jane Perlmutter provided the patient advocate’s perspective in these discussions. All I-SPY2 trial investigators participated in the review of current standards, had the opportunity to participate in and comment on proposed standards and the final manuscript. Gill Hirst and Smita Asare provided expertise on, conducted and analyzed surveys of I-SPY trial sites. Jeffrey B. Matthews provided significant input and editing throughout the manuscript development process. All authors reviewed manuscript drafts and signed off on the final manuscript. This has been corrected in the HTML and PDF version of the article.

Original languageEnglish (US)
Article number2
Journalnpj Breast Cancer
Volume5
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Axilla
Manuscripts
Clinical Trials
Breast Neoplasms
Jasminum
Research Personnel

Cite this

@article{b95d982d94e94029b20dcb90da01c21a,
title = "Erratum to: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)",
abstract = "In the original version of the published article, Constantine Godellas was mistakenly omitted from the Author list and Author Contributions statement. Constantine Godellas has been added as the 29th Author, and is affiliated with Loyola University Medical Center, Maywood, IL, United States. The author contributions statement has been updated as follows: “Author Contributions Statement: Judy C. Boughey conducted the review of current protocols, led the effort to establish new I-SPY standards and was the principal author of the manuscript. Laura Esserman co-led the review and standardization processes. Michael D. Alvarado, Rachael B. Lancaster, Fraser Symmans, W, Rita Mukhtar, Jasmine Wong, Cheryl Ewing, David Potter, Todd Tuttle, Tina Hieken, Jodi Carter, James Jakub, Henry Kaplan, Claire Buchanan, Nora Jaskowiak, Husain Sattar, Jeffrey Mueller, Rita Nanda, Claudine Isaacs, Paula Pohlmann, Filipa Lynce, Eleni Tousimis, Jay Zeck, M. Catherine Lee, Julie Lang, Paulette Mhawech-Fauceglia, Roshni Rao, Bret Taback, Margaret Chen, Kevin Kalinsky, Hanina Hibshoosh, Brigid Killelea, Constantine Godellas, and Tara Sanft provided medical and scientific expertise/opinion towards the development of I-SPY standards. Jane Perlmutter provided the patient advocate’s perspective in these discussions. All I-SPY2 trial investigators participated in the review of current standards, had the opportunity to participate in and comment on proposed standards and the final manuscript. Gill Hirst and Smita Asare provided expertise on, conducted and analyzed surveys of I-SPY trial sites. Jeffrey B. Matthews provided significant input and editing throughout the manuscript development process. All authors reviewed manuscript drafts and signed off on the final manuscript. This has been corrected in the HTML and PDF version of the article.",
author = "{I-SPY2 Investigators} and Boughey, {Judy C.} and Alvarado, {Michael D.} and Lancaster, {Rachael B.} and Symmans, {W. Fraser} and Rita Mukhtar and Wong, {Jasmine M.} and Ewing, {Cheryl A.} and Potter, {David A.} and Tuttle, {Todd M.} and Hieken, {Tina J.} and Carter, {Jodi M.} and Jakub, {James W.} and Kaplan, {Henry G.} and Buchanan, {Claire L.} and Jaskowiak, {Nora T.} and Sattar, {Husain A.} and Jeffrey Mueller and Rita Nanda and Isaacs, {Claudine J.} and Pohlmann, {Paula R.} and Filipa Lynce and Tousimis, {Eleni A.} and Zeck, {Jay C.} and Lee, {M. Catherine} and Lang, {Julie E.} and Paulette Mhawech-Fauceglia and Roshni Rao and Bret Taback and Constantine Goodellas and Margaret Chen and Kalinsky, {Kevin M.} and Hanina Hibshoosh and Brigid Killelea and Tara Sanft and Hirst, {Gillian L.} and Smita Asare and Matthews, {Jeffrey B.} and Jane Perlmutter and Esserman, {Laura J.} and Chien, {A. Jo} and Andres Forero-Torres and Douglas Yee and Ellis, {Erin D.} and Han, {Heather S.} and Janice Lu and Wallace, {Anne M.} and Albain, {Kathy S.} and Elias, {Anthony D.} and Clark, {Amy S.} and Kathleen Kemmer",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41523-018-0096-0",
language = "English (US)",
volume = "5",
journal = "npj Breast Cancer",
issn = "2374-4677",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Erratum to

T2 - Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)

AU - I-SPY2 Investigators

AU - Boughey, Judy C.

AU - Alvarado, Michael D.

AU - Lancaster, Rachael B.

AU - Symmans, W. Fraser

AU - Mukhtar, Rita

AU - Wong, Jasmine M.

AU - Ewing, Cheryl A.

AU - Potter, David A.

AU - Tuttle, Todd M.

AU - Hieken, Tina J.

AU - Carter, Jodi M.

AU - Jakub, James W.

AU - Kaplan, Henry G.

AU - Buchanan, Claire L.

AU - Jaskowiak, Nora T.

AU - Sattar, Husain A.

AU - Mueller, Jeffrey

AU - Nanda, Rita

AU - Isaacs, Claudine J.

AU - Pohlmann, Paula R.

AU - Lynce, Filipa

AU - Tousimis, Eleni A.

AU - Zeck, Jay C.

AU - Lee, M. Catherine

AU - Lang, Julie E.

AU - Mhawech-Fauceglia, Paulette

AU - Rao, Roshni

AU - Taback, Bret

AU - Goodellas, Constantine

AU - Chen, Margaret

AU - Kalinsky, Kevin M.

AU - Hibshoosh, Hanina

AU - Killelea, Brigid

AU - Sanft, Tara

AU - Hirst, Gillian L.

AU - Asare, Smita

AU - Matthews, Jeffrey B.

AU - Perlmutter, Jane

AU - Esserman, Laura J.

AU - Chien, A. Jo

AU - Forero-Torres, Andres

AU - Yee, Douglas

AU - Ellis, Erin D.

AU - Han, Heather S.

AU - Lu, Janice

AU - Wallace, Anne M.

AU - Albain, Kathy S.

AU - Elias, Anthony D.

AU - Clark, Amy S.

AU - Kemmer, Kathleen

PY - 2019/12/1

Y1 - 2019/12/1

N2 - In the original version of the published article, Constantine Godellas was mistakenly omitted from the Author list and Author Contributions statement. Constantine Godellas has been added as the 29th Author, and is affiliated with Loyola University Medical Center, Maywood, IL, United States. The author contributions statement has been updated as follows: “Author Contributions Statement: Judy C. Boughey conducted the review of current protocols, led the effort to establish new I-SPY standards and was the principal author of the manuscript. Laura Esserman co-led the review and standardization processes. Michael D. Alvarado, Rachael B. Lancaster, Fraser Symmans, W, Rita Mukhtar, Jasmine Wong, Cheryl Ewing, David Potter, Todd Tuttle, Tina Hieken, Jodi Carter, James Jakub, Henry Kaplan, Claire Buchanan, Nora Jaskowiak, Husain Sattar, Jeffrey Mueller, Rita Nanda, Claudine Isaacs, Paula Pohlmann, Filipa Lynce, Eleni Tousimis, Jay Zeck, M. Catherine Lee, Julie Lang, Paulette Mhawech-Fauceglia, Roshni Rao, Bret Taback, Margaret Chen, Kevin Kalinsky, Hanina Hibshoosh, Brigid Killelea, Constantine Godellas, and Tara Sanft provided medical and scientific expertise/opinion towards the development of I-SPY standards. Jane Perlmutter provided the patient advocate’s perspective in these discussions. All I-SPY2 trial investigators participated in the review of current standards, had the opportunity to participate in and comment on proposed standards and the final manuscript. Gill Hirst and Smita Asare provided expertise on, conducted and analyzed surveys of I-SPY trial sites. Jeffrey B. Matthews provided significant input and editing throughout the manuscript development process. All authors reviewed manuscript drafts and signed off on the final manuscript. This has been corrected in the HTML and PDF version of the article.

AB - In the original version of the published article, Constantine Godellas was mistakenly omitted from the Author list and Author Contributions statement. Constantine Godellas has been added as the 29th Author, and is affiliated with Loyola University Medical Center, Maywood, IL, United States. The author contributions statement has been updated as follows: “Author Contributions Statement: Judy C. Boughey conducted the review of current protocols, led the effort to establish new I-SPY standards and was the principal author of the manuscript. Laura Esserman co-led the review and standardization processes. Michael D. Alvarado, Rachael B. Lancaster, Fraser Symmans, W, Rita Mukhtar, Jasmine Wong, Cheryl Ewing, David Potter, Todd Tuttle, Tina Hieken, Jodi Carter, James Jakub, Henry Kaplan, Claire Buchanan, Nora Jaskowiak, Husain Sattar, Jeffrey Mueller, Rita Nanda, Claudine Isaacs, Paula Pohlmann, Filipa Lynce, Eleni Tousimis, Jay Zeck, M. Catherine Lee, Julie Lang, Paulette Mhawech-Fauceglia, Roshni Rao, Bret Taback, Margaret Chen, Kevin Kalinsky, Hanina Hibshoosh, Brigid Killelea, Constantine Godellas, and Tara Sanft provided medical and scientific expertise/opinion towards the development of I-SPY standards. Jane Perlmutter provided the patient advocate’s perspective in these discussions. All I-SPY2 trial investigators participated in the review of current standards, had the opportunity to participate in and comment on proposed standards and the final manuscript. Gill Hirst and Smita Asare provided expertise on, conducted and analyzed surveys of I-SPY trial sites. Jeffrey B. Matthews provided significant input and editing throughout the manuscript development process. All authors reviewed manuscript drafts and signed off on the final manuscript. This has been corrected in the HTML and PDF version of the article.

UR - http://www.scopus.com/inward/record.url?scp=85059534138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059534138&partnerID=8YFLogxK

U2 - 10.1038/s41523-018-0096-0

DO - 10.1038/s41523-018-0096-0

M3 - Comment/debate

C2 - 30675512

AN - SCOPUS:85059534138

VL - 5

JO - npj Breast Cancer

JF - npj Breast Cancer

SN - 2374-4677

IS - 1

M1 - 2

ER -